Hi-Tech Pharmacal Co. (HITK) Misses Q3 EPS by 28c
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Income from continuing operations before income tax expense: 12.31M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income from continuing operations before income tax expense: 12.31M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q3 EPS of $0.43, $0.28 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $64.33 million versus the consensus estimate of $60.45 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- UBS says bull market has further to run
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
